Roginolisib (IOA-244)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Roginolisib (IOA-244), covering 2026-01-16 to 2026-02-11. Get the full timeline:
Most recent: Clinical Trial Update: Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL) [Phase 1, Phase 2]